About cyclopropyl-[5-[(3,4-dimethoxyphenyl)methyl]-1,2,4-oxadiazol-3-yl]methanamine
cyclopropyl-[5-[(3,4-dimethoxyphenyl)methyl]-1,2,4-oxadiazol-3-yl]methanamine (PubChem CID 61325866) has the molecular formula C15H19N3O3
and a molecular weight of 289.34 g/mol. Its IUPAC name is cyclopropyl-[5-[(3,4-dimethoxyphenyl)methyl]-1,2,4-oxadiazol-3-yl]methanamine.
Analyze cyclopropyl-[5-[(3,4-dimethoxyphenyl)methyl]-1,2,4-oxadiazol-3-yl]methanamine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of cyclopropyl-[5-[(3,4-dimethoxyphenyl)methyl]-1,2,4-oxadiazol-3-yl]methanamine?
The IUPAC name of cyclopropyl-[5-[(3,4-dimethoxyphenyl)methyl]-1,2,4-oxadiazol-3-yl]methanamine (CID 61325866) is cyclopropyl-[5-[(3,4-dimethoxyphenyl)methyl]-1,2,4-oxadiazol-3-yl]methanamine.
What is the SMILES notation for cyclopropyl-[5-[(3,4-dimethoxyphenyl)methyl]-1,2,4-oxadiazol-3-yl]methanamine?
The canonical SMILES for cyclopropyl-[5-[(3,4-dimethoxyphenyl)methyl]-1,2,4-oxadiazol-3-yl]methanamine is COc1ccc(Cc2nc(C(N)C3CC3)no2)cc1OC.
What is the InChIKey of cyclopropyl-[5-[(3,4-dimethoxyphenyl)methyl]-1,2,4-oxadiazol-3-yl]methanamine?
The InChIKey is QZFJQBZKVKKVGU-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H19N3O3/c1-19-11-6-3-9(7-12(11)20-2)8-13-17-15(18-21-13)14(16)10-4-5-10/h3,6-7,10,14H,4-5,8,16H2,1-2H3.
What are the key properties of cyclopropyl-[5-[(3,4-dimethoxyphenyl)methyl]-1,2,4-oxadiazol-3-yl]methanamine?
cyclopropyl-[5-[(3,4-dimethoxyphenyl)methyl]-1,2,4-oxadiazol-3-yl]methanamine has a molecular weight of 289.34 g/mol, XLogP of 2.09, 6 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for cyclopropyl-[5-[(3,4-dimethoxyphenyl)methyl]-1,2,4-oxadiazol-3-yl]methanamine is sourced from PubChem (CID 61325866), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).